Evidence map›Paper›PMID 28525648›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2017

The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment.

Erica K Brockmeier, Geoff Hodges, Thomas H Hutchinson, Emma Butler, Markus Hecker, Knut Erik Tollefsen, Natalia Garcia-Reyero, Peter Kille, Dörthe Becker, Kevin Chipman and 18 more

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. A workflow for human health hazard evaluation using transcriptomic data and Key Characteristics-based gene sets.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Erica K BrockmeierInstitute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
Geoff HodgesSafety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook MK44 1LQ, UK.
Thomas H HutchinsonSchool of Biological Sciences, University of Plymouth, Plymouth, Devon PL4 8AA, UK.
Emma ButlerSafety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook MK44 1LQ, UK.
Markus HeckerToxicology Centre and School of the Environment and Sustainability, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5B3, Canada.
Knut Erik TollefsenNorwegian Institute for Water Research (NIVA), N-0349 Oslo, Norway.
Natalia Garcia-ReyeroUS Army Engineer Research and Development Center, Vicksburg, Mississippi.
Peter KilleCardiff School of Biosciences, University of Cardiff, Cardiff CF10 3AT, UK.
Dörthe BeckerSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Kevin ChipmanSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
John ColbourneSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Timothy W ColletteNational Exposure Research Laboratory, U.S. Environmental Protection Agency, Athens, Georgia 30605-2700.
Andrew CossinsInstitute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
Mark CroninSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
Peter GraystockDepartment of Entomology, University of California, Riverside, California 92521.
Steve GutsellSafety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook MK44 1LQ, UK.
Dries KnapenZebrafishlab, University of Antwerp, Universiteitsplein 1, Belgium.
Ioanna KatsiadakiCentre for Environment, Fisheries and Aquaculture Science (CEFAS), The Nothe, Weymouth, Dorset DT4 8UB, UK.
Anke LangeBiosciences, College of Life and Environmental Sciences, University of Exeter, Exeter EX4 4QD, UK.
Stuart MarshallSafety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook MK44 1LQ, UK.
Stewart F OwenAstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TF, UK.
Edward J PerkinsUS Army Engineer Research and Development Center, Vicksburg, Mississippi.
Stewart PlaistowInstitute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.
Anthony SchroederWater Resources Center (Office: Mid-Continent Ecology Division), University of Minnesota, Minnesota 55108.
Daisy TaylorSchool of Biological Sciences, Life Sciences Building, University of Bristol, Bristol BS8 1TQ, UK.
Mark ViantSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Gerald AnkleyU.S. Environmental Protection Agency, Duluth, Minnesota 55804.
Francesco FalcianiInstitute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK.

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research G0800702/1
6 · The paper itself

Abstract

In conjunction with the second International Environmental Omics Symposium (iEOS) conference, held at the University of Liverpool (United Kingdom) in September 2014, a workshop was held to bring together experts in toxicology and regulatory science from academia, government and industry. The purpose of the workshop was to review the specific roles that high-content omics datasets (eg, transcriptomics, metabolomics, lipidomics, and proteomics) can hold within the adverse outcome pathway (AOP) framework for supporting ecological and human health risk assessments. In light of the growing number of examples of the application of omics data in the context of ecological risk assessment, we considered how omics datasets might continue to support the AOP framework. In particular, the role of omics in identifying potential AOP molecular initiating events and providing supportive evidence of key events at different levels of biological organization and across taxonomic groups was discussed. Areas with potential for short and medium-term breakthroughs were also discussed, such as providing mechanistic evidence to support chemical read-across, providing weight of evidence information for mode of action assignment, understanding biological networks, and developing robust extrapolations of species-sensitivity. Key challenges that need to be addressed were considered, including the need for a cohesive approach towards experimental design, the lack of a mutually agreed framework to quantitatively link genes and pathways to key events, and the need for better interpretation of chemically induced changes at the molecular level. This article was developed to provide an overview of ecological risk assessment process and a perspective on how high content molecular-level datasets can support the future of assessment procedures through the AOP framework.

Indexed as

Adverse Outcome PathwaysLipid MetabolismMetabolomicsProteomicsTranscriptomeAnimalsHumansRisk Assessmentin vitro and alternativesmethodspredictive toxicologyregulatory/policyrisk assessmenttoxicogenomics

Identifiers

PMID28525648
PMCPMC5837273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.